Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Gemcitabine Plus High-Dose Ascorbate in Locally Advanced Unresectable or Metastatic Soft Tissue and Bone Sarcomas Including Adolescents

NCT04877587 is registered in ClinicalTrials.gov with David Dickens as lead sponsor.

NCT NCT04877587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04877587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Gemcitabine Plus High-Dose Ascorbate in Locally Advanced Unresectable or Metastatic Soft Tissue and Bone Sarcomas Including Adolescents
Lead sponsor
David Dickens
Phase
Phase 1
Overall status
Withdrawn
Start date
January 31, 2023
Completion date
May 31, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone sarcoma, metastatic bone sarcoma, metastatic soft-tissue sarcoma, soft tissue sarcoma, unresectable bone sarcoma, unresectable soft tissue sarcoma